• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测特发性炎性肌病患者感染事件发生率的列线图的开发与验证

Development and validation of a nomogram for predicting the incidence of infectious events in patients with idiopathic inflammatory myopathies.

作者信息

Yang Luwei, Fan Guihua, Zhang Lijuan, Zhou Binbin, Dai Xiaomin, Ji Zongfei, Ma Lingying, Zhang Zhuojun, Chen Huiyong, Yu Qiang, Ma Lili, Jiang Lindi, Sun Ying

机构信息

Department of Rheumatology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.

Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Front Immunol. 2025 Mar 5;16:1471152. doi: 10.3389/fimmu.2025.1471152. eCollection 2025.

DOI:10.3389/fimmu.2025.1471152
PMID:40109346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11920973/
Abstract

BACKGROUND

Infection is a leading cause of mortality in idiopathic inflammatory myopathies (IIMs). This study aimed to develop a nomogram for predicting severe infection risk in IIM patients.

METHODS

Patients with IIMs admitted to Zhongshan Hospital, Fudan University, from January 2015 to January 2022 were enrolled. They were randomly divided into derivation (70%) and validation (30%) sets. Univariate and multivariate Cox regression identified independent risk factors for severe infection, and the Akaike information criterion (AIC) was applied for model selection. A nomogram was constructed to predict severe infection risks at 6 months, 1 year, and 3 years. Predictive accuracy and discriminative ability were evaluated using the concordance index (C-index), calibration curves, and the area under the receiver operating characteristic curve (AUC). Decision curve analysis (DCA) assessed clinical utility. Kaplan-Meier (K-M) curves were used to analyze survival differences between high- and low-risk groups stratified by nomogram scores.

RESULTS

Among 263 IIM patients, 81 experienced 106 severe infection events, with lower respiratory tract infections being the most common (47.2%). Independent risk factors included age at onset (HR 1.024, 95% CI 1.002-1.046, =0.036), lactate dehydrogenase (HR 1.002, 95% CI 0.999-1.005, =0.078), HRCT score (HR 1.004, 95% CI 1.001-1.006, =0.002), and lymphocyte count (HR 0.48, 95% CI 0.23-0.99, =0.048). The nomogram demonstrated strong predictive performance, with AUCs of 0.84, 0.83, and 0.78 for 6 months, 1 year, and 3 years in the derivation set, and 0.91, 0.77, and 0.64 in the validation set. Calibration curves showed good agreement between predicted and observed risks, while DCA demonstrated significant net benefit over individual predictors. Kaplan-Meier curves revealed significant differences in the cumulative risk of severe infection between high- and low-risk groups. Further validation in DM and ASS subgroups demonstrated that the nomogram effectively predicted severe infections, with AUCs of 0.86, 0.81, and 0.73 for DM and 0.86, 0.83, and 0.74 for ASS at 6 months, 1 year, and 3 years, respectively.

CONCLUSION

We have developed a new nomogram to predict severe infection risk in IIM patients at 6 months, 1 year, and 3 years. This model aids clinicians and patients in formulating treatment and follow-up strategies.

摘要

背景

感染是特发性炎症性肌病(IIM)患者死亡的主要原因。本研究旨在开发一种列线图,用于预测IIM患者发生严重感染的风险。

方法

纳入2015年1月至2022年1月在复旦大学附属中山医院住院的IIM患者。将他们随机分为推导组(70%)和验证组(30%)。单因素和多因素Cox回归确定严重感染的独立危险因素,并应用赤池信息准则(AIC)进行模型选择。构建列线图以预测6个月、1年和3年时的严重感染风险。使用一致性指数(C指数)、校准曲线和受试者工作特征曲线下面积(AUC)评估预测准确性和判别能力。决策曲线分析(DCA)评估临床实用性。采用Kaplan-Meier(K-M)曲线分析按列线图评分分层的高风险组和低风险组之间的生存差异。

结果

在263例IIM患者中,81例发生了106次严重感染事件,其中下呼吸道感染最为常见(47.2%)。独立危险因素包括发病年龄(HR 1.024,95%CI 1.002-1.046,P=0.036)、乳酸脱氢酶(HR 1.002,95%CI 0.999-1.005,P=0.078)、HRCT评分(HR 1.004,95%CI 1.001-1.006,P=0.002)和淋巴细胞计数(HR 0.48,95%CI 0.23-0.99,P=0.048)。列线图显示出强大的预测性能,推导组中6个月、1年和3年的AUC分别为0.84、0.83和0.78,验证组中分别为0.91、0.77和0.64。校准曲线显示预测风险与观察到的风险之间具有良好的一致性,而DCA显示出比个体预测指标更大的净效益。Kaplan-Meier曲线显示高风险组和低风险组之间严重感染的累积风险存在显著差异。在皮肌炎(DM)和抗合成酶综合征(ASS)亚组中的进一步验证表明,列线图能有效预测严重感染,DM组在6个月、1年和3年时的AUC分别为0.86、0.81和0.73,ASS组分别为0.86、0.83和0.74。

结论

我们开发了一种新的列线图,用于预测IIM患者在6个月、1年和3年时发生严重感染的风险。该模型有助于临床医生和患者制定治疗和随访策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/6920a6e6b43c/fimmu-16-1471152-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/9efe7915a142/fimmu-16-1471152-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/61a2ec1f62dc/fimmu-16-1471152-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/e68019dbcd62/fimmu-16-1471152-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/aa708e61e23b/fimmu-16-1471152-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/5bd02f3391f3/fimmu-16-1471152-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/6856c5429890/fimmu-16-1471152-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/6920a6e6b43c/fimmu-16-1471152-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/9efe7915a142/fimmu-16-1471152-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/61a2ec1f62dc/fimmu-16-1471152-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/e68019dbcd62/fimmu-16-1471152-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/aa708e61e23b/fimmu-16-1471152-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/5bd02f3391f3/fimmu-16-1471152-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/6856c5429890/fimmu-16-1471152-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f073/11920973/6920a6e6b43c/fimmu-16-1471152-g007.jpg

相似文献

1
Development and validation of a nomogram for predicting the incidence of infectious events in patients with idiopathic inflammatory myopathies.预测特发性炎性肌病患者感染事件发生率的列线图的开发与验证
Front Immunol. 2025 Mar 5;16:1471152. doi: 10.3389/fimmu.2025.1471152. eCollection 2025.
2
Predicting Overall Survival in Patients with Male Breast Cancer: Nomogram Development and External Validation Study.预测男性乳腺癌患者的总生存期:列线图的构建与外部验证研究
JMIR Cancer. 2025 Mar 4;11:e54625. doi: 10.2196/54625.
3
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
4
[Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].[一种预测根治性肾切除术后总生存期的新型列线图的建立与验证]
Zhonghua Zhong Liu Za Zhi. 2023 Aug 23;45(8):681-689. doi: 10.3760/cma.j.cn112152-20221027-00722.
5
Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram.人表皮生长因子受体 2 阳性乳腺癌患者新辅助治疗后预后因素:预测列线图的建立与验证。
Pathol Res Pract. 2024 Sep;261:155504. doi: 10.1016/j.prp.2024.155504. Epub 2024 Jul 31.
6
A prognostic nomogram and risk classification system of elderly patients with extraosseous plasmacytoma: a SEER database analysis.基于 SEER 数据库分析的老年骨外浆细胞瘤患者预后列线图和风险分级系统。
J Cancer Res Clin Oncol. 2023 Dec;149(20):17921-17931. doi: 10.1007/s00432-023-05492-6. Epub 2023 Nov 13.
7
Development of a novel dynamic nomogram for predicting overall survival in anaplastic thyroid cancer patients with distant metastasis: a population-based study based on the SEER database.基于 SEER 数据库的人群研究:开发一种新的预测伴远处转移的间变性甲状腺癌患者总生存的动态列线图
Front Endocrinol (Lausanne). 2024 Jul 4;15:1375176. doi: 10.3389/fendo.2024.1375176. eCollection 2024.
8
Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.基于人群的回顾性研究:用于评估宫颈神经内分泌癌患者总生存和癌症特异性生存的竞争风险列线图和风险分类系统。
J Endocrinol Invest. 2024 Jun;47(6):1545-1557. doi: 10.1007/s40618-023-02261-7. Epub 2024 Jan 3.
9
[Development and validation of a prognostic model for patients with sepsis in intensive care unit].[重症监护病房脓毒症患者预后模型的开发与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):800-806. doi: 10.3760/cma.j.cn121430-20230103-00003.
10
Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma.建立预测小肝细胞癌患者微血管侵犯和早期复发的列线图。
BMC Cancer. 2024 Aug 1;24(1):929. doi: 10.1186/s12885-024-12655-2.

本文引用的文献

1
Management of immune-mediated necrotizing myopathy.免疫介导性坏死性肌病的治疗。
Muscle Nerve. 2024 Aug;70(2):166-172. doi: 10.1002/mus.28114. Epub 2024 May 27.
2
Immune-Mediated Necrotizing Myopathies: Current Landscape.免疫介导性坏死性肌病:现状。
Curr Neurol Neurosci Rep. 2024 May;24(5):141-150. doi: 10.1007/s11910-024-01337-y. Epub 2024 Apr 9.
3
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
4
Autoimmune inflammatory myopathies.自身免疫性炎性肌病。
Handb Clin Neurol. 2023;195:425-460. doi: 10.1016/B978-0-323-98818-6.00023-6.
5
Risk of Early Infection in Idiopathic Inflammatory Myopathies: Cluster Analysis Based on Clinical Features and Biomarkers.特发性炎性肌病早期感染风险:基于临床特征和生物标志物的聚类分析
Inflammation. 2023 Jun;46(3):1036-1046. doi: 10.1007/s10753-023-01790-w. Epub 2023 Feb 13.
6
Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.鉴定抗黑色素瘤分化相关基因 5 抗体阳性皮肌炎患者的三种不同表型:对快速进展性间质性肺病预测的影响。
Arthritis Rheumatol. 2023 Apr;75(4):609-619. doi: 10.1002/art.42308. Epub 2023 Mar 17.
7
Idiopathic inflammatory myopathies.特发性炎性肌病
Nat Rev Dis Primers. 2021 Dec 2;7(1):86. doi: 10.1038/s41572-021-00321-x.
8
Association of Cytomegalovirus Infection With Anti-MDA5 Antibody-Positive Dermatomyositis: A Prospective Cohort Study.巨细胞病毒感染与抗MDA5抗体阳性皮肌炎的关联:一项前瞻性队列研究。
Front Med (Lausanne). 2021 Oct 8;8:740154. doi: 10.3389/fmed.2021.740154. eCollection 2021.
9
Nomogram to predict dermatomyositis prognosis: a population-based study of 457 cases.预测皮肌炎预后的列线图:一项基于人群的 457 例研究。
Clin Exp Rheumatol. 2022 Feb;40(2):247-253. doi: 10.55563/clinexprheumatol/0ddt88. Epub 2021 Sep 10.
10
Infection is not rare in patients with idiopathic inflammatory myopathies.在特发性炎性肌病患者中,感染并不罕见。
Clin Exp Rheumatol. 2022 Feb;40(2):254-259. doi: 10.55563/clinexprheumatol/yps7ai. Epub 2021 Jul 21.